Comparison
46 Xy True Hermaphroditism C2748897 vs Abnormal Plasma Transport Protein Cn379676
Clinical comparison between 46 XY True Hermaphroditism and Abnormal Plasma Transport Protein CN379676 for differential diagnosis and treatment planning.
46 Xy True Hermaphroditism C2748897
A rare disorder of sex development where individuals have both ovarian and testicular tissue, typically in those with XY chromosomes.
Abnormal Plasma Transport Protein Cn379676
A category of conditions where proteins in blood plasma that carry drugs, hormones, or other substances do not function normally. Treatment depends on which transport protein is affected.
6 comparison axes
Onset
46 Xy True Hermaphroditism C2748897
0-null
Abnormal Plasma Transport Protein Cn379676
Variable
Onset patterns differ
Severity
46 Xy True Hermaphroditism C2748897
severe
Abnormal Plasma Transport Protein Cn379676
mild
Different severity levels
Chronic
46 Xy True Hermaphroditism C2748897
Chronic
Abnormal Plasma Transport Protein Cn379676
Chronic
Differing course
Communicable
46 Xy True Hermaphroditism C2748897
No
Abnormal Plasma Transport Protein Cn379676
No
Different transmission
Body System
46 Xy True Hermaphroditism C2748897
reproductive
Abnormal Plasma Transport Protein Cn379676
metabolic
Same/different system
Category
46 Xy True Hermaphroditism C2748897
genetic
Abnormal Plasma Transport Protein Cn379676
metabolic
Different category
Bottom line
46-xy-true-hermaphroditism-C2748897 and abnormal-plasma-transport-protein-CN379676 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy True Hermaphroditism C2748897 | Abnormal Plasma Transport Protein Cn379676 | Discriminating power |
|---|---|---|---|
| Genital or reproductive presentation | Atypical genital or gonadal findings may be present from early life, but features vary. | No characteristic genital presentation is established by this category alone. | High |
| Hormone or drug-level abnormality | Sex-hormone patterns may be atypical, but no single pattern is definitive. | Measured substance levels may be misleading if a carrier protein functions abnormally. | Moderate |
| Systemic metabolic symptoms | Systemic metabolic disease is not the defining feature. | Symptoms, if any, depend on the specific protein and substance affected. | Moderate |
When to favor each condition
Choose 46 Xy True Hermaphroditism C2748897 when
Both ovarian and testicular tissue are documented
Tissue findings support ovotesticular disorder of sex development rather than a transport-protein category.
High
46,XY karyotype with atypical gonadal development
Chromosomal and gonadal evaluation points toward a disorder of sex development.
Moderate
Early-life reproductive anatomy concern
Onset and reproductive-system involvement fit the left concept better.
Moderate
Choose Abnormal Plasma Transport Protein Cn379676 when
Unexpected blood level of a carried substance
A transport-protein abnormality may explain discordant laboratory results.
Moderate
No gonadal or genital abnormality
Absence of reproductive findings makes the left diagnosis less likely.
Moderate
A specific carrier protein is implicated
Management depends on which protein and substance are affected.
High
How key tests differ
| Test | 46 Xy True Hermaphroditism C2748897 | Abnormal Plasma Transport Protein Cn379676 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY may be present, but karyotype alone does not prove the diagnosis. | No characteristic karyotype is established. | Use with gonadal and clinical findings. |
| Gonadal histology | Both ovarian and testicular tissue support the diagnosis. | Not expected to define this category. | Histology is central for the left concept. |
| Plasma protein or binding studies | Not the primary diagnostic test. | May show abnormal quantity or function of a carrier protein. | Interpret with the specific substance and clinical context. |
Prognosis comparison
46 Xy True Hermaphroditism C2748897
- Outcome
- Often a lifelong condition with individualized reproductive and endocrine needs.
- Factors
- Gonadal findings, hormone function, anatomy, and access to specialist care.
Abnormal Plasma Transport Protein Cn379676
- Outcome
- Often mild, but outcome depends entirely on the specific protein and substance.
- Factors
- Protein involved, degree of dysfunction, and clinical consequences.
Time frame: Both may be chronic; onset is typically early for the left and variable for the right.
Prognosis cannot be generalized from these sparse source descriptions.
Complications comparison
| Complication | Presentation |
|---|---|
| Fertility or gonadal concerns | Fertility and gonadal-risk issues may require specialist assessment. Not an established feature of the category itself. Exact risks are not established here. |
| Misinterpreted laboratory results | Hormone results need context but are not primarily binding artifacts. Abnormal transport can distort measured levels or apparent exposure. Confirm which protein is involved. |
| Treatment mismatch | Care may involve endocrine, surgical, and psychosocial decisions. Treatment varies by protein and may affect drug or hormone handling. No universal dose or regimen is implied. |
Patient education highlights
- HighDifferent conditions
These are not interchangeable: one concerns gonadal development, the other blood transport proteins.
- HighSpecialist interpretation
Diagnosis and implications should be confirmed by an appropriate clinician.
- MediumRespectful terminology
46,XY true hermaphroditism is an older term; ovotesticular disorder of sex development is often preferred.